1. Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Issue 10274 (13th February 2021) Authors: Abaleke, Eugenia; Abbas, Mustafa; Abbasi, Sadia; Abbott, Alfie; Abdelaziz, Ashraf; Abdelbadiee, Sherif; Abdelfattah, Mohamed; Abdul, Basir; Abdul Rasheed, Althaf; Abdul-Kadir, Rezan; Abdulmumeen, Abdulfatahi; Abdulshukkoor, Niyaz; Abdusamad, Kula; Abed El Khaleq, Yazeed; Abedalla, Mai; Abeer Ul A... Journal: Lancet Issue: Volume 397:Issue 10274(2021) Page Start: 605 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis. Issue 10349 (30th July 2022) Authors: Abani, Obbina; Abbas, Ali; Abbas, Fatima; Abbas, Joshua; Abbas, Kasim; Abbas, Mustafa; Abbasi, Sadia; Abbass, Hakam; Abbott, Alfie; Abbott, Alison; Abdallah, Nabeel; Abdelaziz, Ammar; Abdelaziz, Ashraf; Abdelfattah, Mohamed; Abdelqader, Bushra; Abdul, Audrey; Abdul, Basir; Abdul, Siddiqui; Abdul ... Journal: Lancet Issue: Volume 400:Issue 10349(2022) Page Start: 359 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Issue 10325 (12th February 2022) Authors: Abani, Obbina; Abbas, Ali; Abbas, Fatima; Abbas, Mustafa; Abbasi, Sadia; Abbass, Hakam; Abbott, Alfie; Abdallah, Nabeel; Abdelaziz, Ashraf; Abdelfattah, Mohamed; Abdelqader, Bushra; Abdul, Basir; Abdul Rasheed, Althaf; Abdulakeem, Ajibode; Abdul-Kadir, Rezan; Abdullah, Abdullah; Abdulmumeen, Abdu... Journal: Lancet Issue: Volume 399:Issue 10325(2022) Page Start: 665 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Effect of a 2-week interruption in methotrexate treatment versus continued treatment on COVID-19 booster vaccine immunity in adults with inflammatory conditions (VROOM study): a randomised, open label, superiority trial. Issue 9 (September 2022) Authors: Abhishek, Abhishek; Boyton, Rosemary J; Peckham, Nicholas; McKnight, Áine; Coates, Laura C; Bluett, James; Barber, Vicki; Cureton, Lucy; Francis, Anne; Appelbe, Duncan; Eldridge, Lucy; Julier, Patrick; Valdes, Ana M; Brooks, Tim; Rombach, Ines; Altmann, Daniel M; Nguyen-Van-Tam, Jonathan S; Willi... Journal: Lancet Issue: Volume 10:Issue 9(2022) Page Start: 840 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. Issue 10387 (6th May 2023) Authors: Abani, Obbina; Abbas, Ali; Abbas, Fatima; Abbas, Joshua; Abbas, Kasim; Abbas, Mustafa; Abbasi, Sadia; Abbass, Hakam; Abbott, Alfie; Abbott, Alison; Abdallah, Nabeel; Abdelaziz, Ammar; Abdelaziz, Ashraf; Abdelfattah, Mohamed; Abdelqader, Bushra; Abdul, Audrey; Abdul, Basir; Abdul, Siddiqui; Abdul ... Journal: Lancet Issue: Volume 401:Issue 10387(2023) Page Start: 1499 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. O19 Secukinumab-related gastrointestinal safety in PsA and AS. (20th April 2020) Authors: Onac, Ioana A; Tacu, Cristina; Clarke, Benjamin D; Lloyd, Mark; Hajela, Vijey; Batty, Thomas; Thoroughgood, Jamie; Smith, Sandra; Irvine, Hannah; Hill, Diane; Baxter, Grace; Horwood, Natalie; Mahendrakar, Suma; Rajak, Rizwan; Griffith, Sian; Kiely, Patrick; Galloway, James B Journal: Rheumatology Issue: Volume 59(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Secukinumab as a potential trigger of inflammatory bowel disease in ankylosing spondylitis or psoriatic arthritis patients. (2nd March 2021) Authors: Onac, Ioana A; Clarke, Benjamin D; Tacu, Cristina; Lloyd, Mark; Hajela, Vijay; Batty, Thomas; Thoroughgood, Jamie; Smith, Sandra; Irvine, Hannah; Hill, Diane; Baxter, Grace; Horwood, Natalie; Mahendrakar, Suma; Rajak, Rizwan; Griffith, Sian; Kiely, Patrick D W; Galloway, James Journal: Rheumatology Issue: Volume 60:Number 11(2021) Page Start: 5233 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Issue 10285 (1st May 2021) Authors: Abani, Obbina; Abbas, Ali; Abbas, Fatima; Abbas, Mustafa; Abbasi, Sadia; Abbass, Hakam; Abbott, Alfie; Abdallah, Nabeel; Abdelaziz, Ashraf; Abdelfattah, Mohamed; Abdelqader, Bushra; Abdul, Basir; Abdul Rasheed, Althaf; Abdulakeem, Ajibode; Abdul-Kadir, Rezan; Abdulmumeen, Abdulfatahi; Abdul-Rahee... Journal: Lancet Issue: Volume 397:Issue 10285(2021) Page Start: 1637 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Unusual presentation of eosinophilic fasciitis (EF) with a raised ALT. Issue 1 (22nd December 2018) Authors: Batty, Thomas; Majeed, Shuja; Wlodek, Christina; Gunawardena, Harsha Journal: BMJ case reports Issue: Volume 11:Issue 1(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗